Your browser doesn't support javascript.
loading
Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma.
Moreau, Philippe; van de Donk, Niels W C J; Delforge, Michel; Einsele, Hermann; De Stefano, Valerio; Perrot, Aurore; Besemer, Britta; Pawlyn, Charlotte; Karlin, Lionel; Manier, Salomon; Leleu, Xavier; Weisel, Katja; Ghilotti, Francesca; Diels, Joris; Elsada, Ahmed; Morano, Raul; Strulev, Vadim; Pei, Lixia; Kobos, Rachel; Smit, Jennifer; Slavcev, Mary; Mateos, Maria-Victoria.
Afiliação
  • Moreau P; Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France.
  • van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Delforge M; University of Leuven, Leuven, Belgium.
  • Einsele H; Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
  • De Stefano V; Section of Hematology, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy.
  • Perrot A; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Besemer B; University of Tübingen, Tübingen, Germany.
  • Pawlyn C; The Institute of Cancer Research, London, UK.
  • Karlin L; Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Manier S; University of Lille, Lille, France.
  • Leleu X; CHU and University, Poitiers, France.
  • Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ghilotti F; Janssen-Cilag SpA, Cologno Monzese, Italy.
  • Diels J; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Elsada A; Janssen-Cilag, High Wycombe, Buckinghamshire, UK.
  • Morano R; Janssen EMEA, Madrid, Spain.
  • Strulev V; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Pei L; Janssen Research & Development, Raritan, NJ, USA.
  • Kobos R; Janssen Research & Development, Raritan, NJ, USA.
  • Smit J; Janssen Research & Development, Spring House, PA, USA.
  • Slavcev M; Janssen Global Services, LLC, Raritan, NJ, USA.
  • Mateos MV; Departamento de Hematología, University Hospital of Salamanca/IBSAL, CIC, Salamanca, Spain. mvmateos@usal.es.
Adv Ther ; 40(5): 2412-2425, 2023 05.
Article em En | MEDLINE | ID: mdl-36961654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article